FDA Requires Boxed Warning for Denosumab (PROLIA) because of an Increased Risk of Severe Hypocalcemia for Some Patients March 1, 2024
Letters, Testimony & Filings Public Citizen Post-Hearing Comment for the 2024 Special 301 Review February 29, 2024
Press Releases FDA Should Protect Patients by Prioritizing Prompt Revisions of Safety Labeling for Drugs February 20, 2024
Letters, Testimony & Filings Activists Urge UNICEF, Gavi, Global Fund, PAHO & PEPFAR: Say “No” to Secrecy in Medical Product Procurement Agreements February 7, 2024